ArticleThe Journal of clinical investigation2011

Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma.

Hideaki Ijichi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.